Shypd.aiThe largest open index of AI toolsIMVARIA is a clinical AI tool that generates novel physiologic signatures from clinical testing and imaging, specializing in lung disease. It offers FDA-authorized AI diagnostic tools for idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD).
Trending
About
IMVARIA is a software-as-medical-device (SaMD) company pioneering AI-driven digital biomarker solutions, primarily focused on lung disease. Their tools, Fibresolve and ScreenDx, are FDA-authorized AI diagnostics for idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD), respectively. Fibresolve provides a diagnostic subtype classification for suspected lung fibrosis, aiding in non-invasive diagnosis and guiding treatment pathways. ScreenDx is a screening algorithm that assesses CT imaging data for findings suggestive of ILD, enhancing referral pathways and early identification. Founded by physician-engineers from Google and Stanford, IMVARIA leverages machine learning and deep-learning models to transform clinical decision-making into data science, aiming to reduce the need for invasive biopsy testing and improve patient outcomes.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check imvaria.com for current pricing.
FAQs
Trending
